MKI67 and invasive breast carcinoma: This result is consistent with that reported by Mori et al. in 2015 in a population of 86 patients with luminal-type invasive breast cancers, suggesting that the mean ROI-ADC of tumors extracted from the same DWI protocol would be useful for estimating the Ki-67 index20.